Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 5/1/2026Shanghai Pharma Completes Exit from Sino-US JV with $140M Stake Sale t...
  • 5/1/2026China Pharma Trade Rises 4.22% in Q1 as Exports Shift Toward High-Valu...
  • 4/30/2026Livzon Takes Control of Vietnam's Imexpharm in $228M Deal
  • 4/30/2026Vivacta Bio Raises $50M+ to Advance In Vivo CAR-T Platform into Clinic...
  • 4/30/2026Kanova Raises Hundreds of Millions in New Round
  • 4/29/2026Samsung Bioepis Expands into China with ATLATL Partnership to Boost In...
  • 4/29/2026AstraZeneca Secures Dual First-Line Liver Cancer Approvals in China fo...
  • 4/29/2026BeOne Expands Multispecific Pipeline With Potential $2B+ HuaHui Immuno...
  • 4/29/2026Aureka Bio Raises $35M to Advance AI-Driven Antibody Discovery Platfor...
  • 4/29/2026Mabwell Lists in Hong Kong in First "A-to-H 18A" Biotech Debut
  • 4/28/2026China Accelerates Biobank Buildout as Data Becomes Strategic Asset in ...
  • 4/28/2026Sun Pharma's $11.75B Organon Deal Signals Major Push Into China Market
  • 4/28/2026QL Biopharma Files Hong Kong IPO to Advance Next-Gen Metabolic Pipelin...
  • 4/27/2026Adcoris Out-Licenses 5T4 ADC to NewCo in Global Deal with K2 Therapeut...
  • 4/27/2026Novamab Raises ~CNY 300M Series B+ to Advance Inhaled and Oral Nanobod...
  • 4/23/2026Hexaell Raises ~CNY 100M in B+ Round to Advance Bio-Artificial Liver P...
  • 4/23/2026Teva Partners with NeuroGen to Expand Migraine Drug Ajovy in China
  • 4/23/2026Tortugas Neuroscience Launches with $106M to Advance China- and Japan-...
  • 4/22/2026Binhui Biopharma Files HKEX IPO, Highlighting HSV-2 Oncolytic Virus Pl...
  • 4/22/2026InxMed Files for Hong Kong IPO, Showcasing Late-Stage Oncology Pipelin...
  • 4/22/2026Pfizer Enters China's Booming GLP-1 Market with Pre-Orders for Weight-...
  • 4/22/2026Chinese Biotech Firms Challenge Western Lead in $16B Parkinson's Treat...
  • 4/22/2026Fusu Life Science Secures Angel Funding to Advance Cell Therapy Ambiti...
  • 4/21/2026Biogen Secures Global Control of Felzartamab with Greater China Rights...
  • 4/20/2026Santen Acquires China Rights to Five AbbVie Glaucoma Drugs in Eye Care...
  • 4/20/2026China Private Biotech Financing Shifts Toward Fewer, Larger Bets in Q1...
  • 4/20/2026Xcovery and EVERSANA Partner to Accelerate U.S. Commercialization of E...
  • 4/20/2026China's Next Leap in Biopharma Innovation: BCG
  • 4/16/2026China Poised to Trigger Global Price War in Weight-Loss Drugs as GLP-1...
  • 4/16/2026Aligos Signs Up to US$445M China HBV Deal With Amoytop for Capsid Asse...
  • Page:1/26 Total number of articles:759: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group